Recursion Pharmaceuticals OverviewRecursion Pharmaceuticals Income Tax
Income tax expense trends for RXRX.
Quarterly Income Tax
-$4.60M
↓ 2813.92% YoY
As of Mar 2026
Annual Income Tax (TTM)
-$4.59M
↓ 580.56% YoY
Trailing 12 months ending Mar 2026
Average Income Tax (Comparison Companies)
Income Tax History
Income Tax Comparison
Annual Income Tax Growth Rate (%)
Loading...
Annual Income Tax Growth (Absolute)
Loading...